Evan Kantor

1.0k total citations
19 papers, 796 citations indexed

About

Evan Kantor is a scholar working on Pharmacology, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Evan Kantor has authored 19 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Epidemiology and 5 papers in Economics and Econometrics. Recurrent topics in Evan Kantor's work include Musculoskeletal pain and rehabilitation (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Evan Kantor is often cited by papers focused on Musculoskeletal pain and rehabilitation (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Evan Kantor collaborates with scholars based in United States, Switzerland and Canada. Evan Kantor's co-authors include Howard G. Birnbaum, James Signorovitch, Jasmina I. Ivanova, M. Schiller, Ralph Swindle, Eric Q. Wu, Bryan M. Johnstone, Andrew P. Yu, Charles M. Gerrits and Yanjun Bao and has published in prestigious journals such as Journal of Clinical Oncology, Alzheimer s & Dementia and Journal of Pain.

In The Last Decade

Evan Kantor

19 papers receiving 771 citations

Peers

Evan Kantor

PHARM

PFM

PMH

David Phillippo United Kingdom

Raye H. Brooks United States

Barry E. Koehler Canada

Jiat Ling Poon United States

Julie Birt United States

Silvia Díaz‐Cerezo Spain

Shiraz R. Gupta United States

Neesha Harnam United States

Ana‐Maria Orbai United States

Michelle K. White United States

David Phillippo United Kingdom

Evan Kantor

72 ×0.3

PHARM

82 ×0.5

PFM

221 ×1.3

42 ×0.5

PMH

235 ×2.6

Citations per year, relative to Evan Kantor Evan Kantor (= 1×) peers David Phillippo

Countries citing papers authored by Evan Kantor

Since Specialization

Citations

This map shows the geographic impact of Evan Kantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Kantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Kantor more than expected).

Fields of papers citing papers by Evan Kantor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Kantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Kantor. The network helps show where Evan Kantor may publish in the future.

Co-authorship network of co-authors of Evan Kantor

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Kantor. A scholar is included among the top collaborators of Evan Kantor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Kantor. Evan Kantor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ivanova, Jasmina I., Howard G. Birnbaum, Evan Kantor, M. Schiller, & Ralph Swindle. (2014). Duloxetine Use in Employees with Low Back Pain: Treatment Patterns and Direct and Indirect Costs. Pain Medicine. 15(6). 1015–1026. 2 indexed citations

Geldmacher, David, Noam Y. Kirson, Howard G. Birnbaum, et al.. (2013). Pre-Diagnosis Excess Acute Care Costs in Alzheimer’s Patients among a US Medicaid Population. Applied Health Economics and Health Policy. 11(4). 407–413. 28 indexed citations

Signorovitch, James, Elyse Swallow, Evan Kantor, et al.. (2013). Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison. Experimental Hematology and Oncology. 2(1). 32–32. 33 indexed citations

Kirson, Noam Y., et al.. (2013). Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis. Journal of Medical Economics. 16(4). 479–489. 21 indexed citations

Geldmacher, David, Noam Y. Kirson, Howard G. Birnbaum, et al.. (2013). Implications of early treatment among Medicaid patients with Alzheimer's disease. Alzheimer s & Dementia. 10(2). 214–224. 36 indexed citations

Ivanova, Jasmina, Howard G. Birnbaum, Evan Kantor, M. Schiller, & Ralph Swindle. (2012). Duloxetine Use in Chronic Low Back Pain. PharmacoEconomics. 30(7). 595–609. 6 indexed citations

Signorovitch, James, Elyse Swallow, Evan Kantor, Xufang Wang, & Peter Metrakos. (2012). Overall survival with everolimus, sunitinib, and placebo for advanced pancreatic neuroendocrine tumors: A matching-adjusted indirect comparison of randomized trials.. Journal of Clinical Oncology. 30(4_suppl). 237–237. 2 indexed citations

Signorovitch, James, Elyse Swallow, Evan Kantor, et al.. (2012). Overall survival with everolimus, sunitinib, and placebo for advanced pancreatic neuroendocrine tumors: A matching-adjusted indirect comparison of randomized trials.. Journal of Clinical Oncology. 30(15_suppl). e14621–e14621. 5 indexed citations

Ivanova, Jasmina, Howard G. Birnbaum, Lei Chen, et al.. (2011). Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.. PubMed. 17(8). e314–23. 45 indexed citations

10.

Signorovitch, James, et al.. (2011). Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 31(9). 665–674. 40 indexed citations

11.

Ivanova, Jasmina I., Howard G. Birnbaum, M. Schiller, et al.. (2011). Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care. The Spine Journal. 11(7). 622–632. 252 indexed citations

12.

Signorovitch, James, Eric Q. Wu, Keith A. Betts, et al.. (2011). Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials. Current Medical Research and Opinion. 27(6). 1263–1271. 42 indexed citations

13.

Birnbaum, Howard G., Rym Ben-Hamadi, David Kelley, et al.. (2010). Assessing the Relationship Between Compliance With Antidepressant Therapy and Employer Costs Among Employees in the United States. Journal of Occupational and Environmental Medicine. 52(2). 115–124. 11 indexed citations

14.

Signorovitch, James, Eric Q. Wu, Andrew P. Yu, et al.. (2010). Comparative Effectiveness Without Head-to-Head Trials. PharmacoEconomics. 28(10). 935–945. 258 indexed citations

15.

Kirson, Noam Y., Jasmina I. Ivanova, Howard G. Birnbaum, et al.. (2010). Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. Journal of Medical Economics. 13(3). 482–491. 7 indexed citations

16.

Kirson, Noam Y., Jasmina I. Ivanova, Howard G. Birnbaum, et al.. (2010). Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%. Journal of Medical Economics. 13(3). 472–481. 4 indexed citations

17.

Ivanova, Jasmina, HG Birnbaum, M. Schiller, et al.. (2009). PSY31 REAL-WORLD USE OF DULOXETINE FOR LOW BACK PAIN. Value in Health. 12(3). A135–A136. 2 indexed citations

18.

Swindle, Ralph, Howard G. Birnbaum, Bryan M. Johnstone, et al.. (2009). Real-world use of duloxetine for low back pain: a propensity score analysis of surgery risk. Journal of Pain. 10(4). S35–S35. 1 indexed citations

19.

Swindle, Ralph, Howard G. Birnbaum, Jasmina I. Ivanova, et al.. (2009). Real-world predictors of surgery in patients with low back pain: a CHAID analysis. Journal of Pain. 10(4). S55–S55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact